Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Filings
Track record
Movers
The Lead Compound
Home
›
Targets
› M1 receptor
M1 receptor
(1 companies · 1 programs)
Companies with an active program directed at M1 receptor.
Contineum Therapeutics, Inc.
CTNM
JNJ-89495120
— Major Depressive Disorder
Phase 2